Texas sues Tylenol makers over alleged deceptive marketing, raising concerns about prenatal acetaminophen use.
Zebra Technologies reports strong Q3 results, but margins decline and guidance raises concerns about execution and the company's shift to software and services.
Texas sues Tylenol makers over alleged deceptive marketing, raising concerns about prenatal acetaminophen use.
Zebra Technologies reports strong Q3 results, but margins decline and guidance raises concerns about execution and the company's shift to software and services.
